AIV Logo AIV Assistant

Loading...

 Logo Shattuck Labs, Inc. - STTK 0.79 USD

EPS
-1.53
P/B
0.41
ROE
-68.48
Beta
1.86

0.791 USD

0.791 USD

Daily: +0.00%
Key Metrics

EPS: -1.53

Book Value: 3.06

Price to Book: 0.41

Debt/Equity: 3.45

% Insiders: 13.414%

Growth

Revenue Growth: 7.05%

Estimates

Forward P/E: -1.35

Forward EPS: -1.07

 Logo About Shattuck Labs, Inc. - (STTK)

Country: United States

Sector: Health Care

Website: http://www.shattucklabs.com

Shattuck Labs, Inc., a clinical-stage biotechnology company, develops therapeutics for the treatment of cancer and autoimmune disease in the United States. The company's lead product candidate is SL-172154, which is in Phase 1 clinical trial for the treatment of ovarian, fallopian tube, and peritoneal cancers. Shattuck Labs, Inc. was incorporated in 2016 and is headquartered in Austin, Texas.

Exchange Ticker
NMS (United States) STTK

Dividends

Historical Split Corporate Actions

Trades
My Trades
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion